Literature DB >> 7586860

Cysticercosis mimicking brain tumor: the role of albendazole as a diagnostic tool.

O H Del Brutto1, L A Quintero.   

Abstract

We report a patient with seizures and a single ringlike enhancing lesion on MRI that resembled a low-grade glioma. The patient received a diagnostic trial with albendazole on the assumption that this lesion could be a cysticercus. Follow-up showed resolution of the brain lesion in 4 weeks. Albendazole administration to patients with single ringlike enhancing lesions may obviate unnecessary surgical procedures in selected cases.

Entities:  

Mesh：

Substances：

Year:  1995        PMID： 7586860     DOI： 10.1016/0303-8467(95)00044-k

Source DB:  PubMed          Journal:  Clin Neurol Neurosurg        ISSN： 0303-8467            Impact factor:   1.876


  3 in total

1.  Publication concerning an article single CT (ring) lesion in epilepsy patients: a new observation by Garg et al, Indian Journal of Pediatrics, January-February, 1999, Vol. 66, No. 1, pages 155-157.

Authors:  H S Duggal; S H Nizamie
Journal:  Indian J Pediatr       Date:  1999 Nov-Dec       Impact factor: 1.967

Review 2.  Current consensus guidelines for treatment of neurocysticercosis.

Authors:  Hector H García; Carlton A W Evans; Theodore E Nash; Osvaldo M Takayanagui; A Clinton White; David Botero; Vedantam Rajshekhar; Victor C W Tsang; Peter M Schantz; James C Allan; Ana Flisser; Dolores Correa; Elsa Sarti; Jon S Friedland; S Manuel Martinez; Armando E Gonzalez; Robert H Gilman; Oscar H Del Brutto
Journal:  Clin Microbiol Rev       Date:  2002-10       Impact factor: 26.132

3.  Monocyte Gene Expression Distinguishes Enhancing Brain Parenchymal Cysticercal Granulomas From Tuberculomas.

Authors:  Betcy Evangeline Pamela; Prabhakaran Vasudevan; Subashini Thamizhmaran; Ranjith K Moorthy; Anna Oommen; Josephin Manoj; Anupriya Thanigachalam; Miao Zhang; Douglas A Drevets; Hélène Carabin; Vedantam Rajshekhar
Journal:  Open Forum Infect Dis       Date:  2021-08-12       Impact factor: 3.835
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.